ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Signs and Symptoms, Respiratory

  • Nebulized Fentanyl for Respiratory Symptoms in Patients With COVID-19
  • Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms.
  • Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:
  • Anakinra for COVID-19 Respiratory Symptoms
  • Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
  • In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?
  • The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms
  • Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program
  • Effect of Intranasal Corticosteroids on Pulmonary Symptoms in Asthmatics With Nasal Congestion
  • GOLD Stage I Chronic Obstructive Pulmonary Disease (COPD)
  • The Effect of Montelukast Treatment in Wheezy Infants
  • Respiratory Side Effects of Busulfan High Dose Chemotherapy in a Pediatric Population
  • An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)
  • Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group